Center for Outcomes and Evidence

Gurvaneet Randhawa, MD

Gurvaneet Randhawa, MD, MPH, works in the Center for Outcomes and Evidence (COE) at the Agency for Healthcare Research and Quality (AHRQ). He is the program officer on all AHRQ grants that will build and enhance clinical electronic data infrastructure to collect and evaluate prospective, patient-centered outcomes for comparative effectiveness research (CER) focusing on AHRQ priority conditions and populations. These grants are part of four programs: scalable distributed research networks, enhanced registries for quality improvement and CER, PROSPECT, and Electronic Data Methods Forum (http://www.edm-forum.org ). These projects will develop electronic clinical infrastructure with the potential capability of performing several functions: CER, quality improvement, disease surveillance and clinical decision support.

Dr. Randhawa also provides scientific direction to clinical genomics-related projects conducted by different AHRQ programs. He is interested in research to improve capabilities of the existing electronic clinical data infrastructure in order to clarify the added value of new diagnostics and therapeutics. He has provided guidance on the development of a new clinical decision support tool for BRCA testing in primary care practice. He has overseen the development of many Evidence-based Practice Center (EPC) reports that systematically and comprehensively clarified the existing evidence on questions of interest to different audiences, including the U.S. Preventive Services Task Force (USPSTF) and the EGAPP working group. He is a past director of the USPSTF program. He has provided programmatic guidance and oversight to the DARTNet project that focused on distributed research in ambulatory care.

Prior to joining AHRQ, Dr. Randhawa completed his Preventive Medicine residency at Johns Hopkins University and his Internal Medicine internship at University of Pennsylvania. Dr. Randhawa also has trained for 9 years in molecular research in two clinical areas, genomic applications in tuberculosis control and in cancer molecular genetics, at two different institutions: Johns Hopkins at Baltimore, Maryland, and M.D. Anderson Cancer Center at Houston, Texas.

 Previous Biography       COE Staff Biographies      Next Biography